tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Ionis Pharmaceuticals Inc

IONS
Add to Watchlist
56.880USD
+1.010+1.81%
Market hours （ET）Quotes delayed by 15 min
9.44BMarket Cap
LossP/E TTM

Ionis Pharmaceuticals Inc

56.880
+1.010+1.81%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

IONS Financials

See Ionis Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Ionis Pharmaceuticals Inc Earnings Date

Latest Release
Jul 29, 2026
EPS / Forecast
--/-1.09
Revenue / Forecast
--/189.03M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
943.71M
33.83%
EPS(YoY)
-2.38
21.49%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
39.37%-0.56
-113.81%-1.41
14.85%-0.80
271.01%0.78
5.66%-0.93
-924.28%-0.66
8.09%-0.95
23.83%-0.45
-12.65%-0.98
82.53%-0.06
---1.03
---0.60
---0.87
---0.37
----
----
----
----
----
----
Revenue
86.98%246.09M
-10.26%203.33M
17.12%156.72M
100.69%452.05M
10.14%131.61M
-30.18%226.58M
-7.21%133.81M
19.55%225.25M
-8.45%119.50M
113.65%324.50M
-9.74%144.21M
40.82%188.41M
-8.03%130.52M
-65.48%151.89M
20.04%159.77M
6.39%133.79M
27.16%141.92M
51.58%440.01M
-16.86%133.09M
-13.60%125.75M
Net Profit
37.03%-92.53M
-119.83%-229.39M
8.45%-128.61M
286.45%123.55M
-2.90%-146.94M
-1026.51%-104.35M
4.70%-140.48M
22.31%-66.27M
-14.86%-142.80M
82.33%-9.26M
-213.69%-147.41M
18.88%-85.29M
-90.78%-124.32M
-123.34%-52.43M
43.02%-46.99M
-30.00%-105.14M
27.49%-65.17M
163.35%224.61M
-237.05%-82.47M
-215.47%-80.88M
Net Margin
66.32%-37.60%
-144.97%-112.82%
21.83%-82.06%
192.91%27.33%
6.58%-111.64%
-1513.41%-46.05%
-2.70%-104.98%
35.01%-29.42%
-25.46%-119.50%
91.73%-2.85%
---102.22%
---45.27%
---95.25%
---34.52%
----
----
----
----
----
----
Gross Margin
-0.10%98.79%
-2.26%96.09%
-0.70%98.51%
0.95%99.08%
0.70%98.89%
-0.75%98.31%
0.73%99.20%
-0.51%98.15%
-0.78%98.20%
1.52%99.06%
--98.48%
--98.65%
--98.97%
--97.57%
----
----
----
----
----
----
Debt to assets ratio
52.51%67.81%
59.51%66.14%
40.82%58.42%
-11.34%42.06%
-3.64%44.46%
-2.67%41.47%
-4.85%41.49%
7.18%47.44%
12.40%46.14%
-9.31%42.60%
--43.60%
--44.27%
--41.05%
--46.97%
----
----
----
----
----
----
Income Statement
Revenue
86.98%246.09M
-10.26%203.33M
17.12%156.72M
100.69%452.05M
10.14%131.61M
-30.18%226.58M
-7.21%133.81M
19.55%225.25M
-8.45%119.50M
113.65%324.50M
-9.74%144.21M
40.82%188.41M
-8.03%130.52M
-65.48%151.89M
20.04%159.77M
6.39%133.79M
27.16%141.92M
51.58%440.01M
-16.86%133.09M
-13.60%125.75M
Operating profit
20.04%-117.42M
-93.51%-214.46M
-7.75%-160.18M
311.55%139.82M
1.77%-146.86M
-2587.92%-110.82M
-18.67%-148.66M
26.72%-66.09M
-30.98%-149.51M
98.02%-4.12M
-111.76%-125.27M
-5.47%-90.19M
-98.50%-114.15M
-194.51%-208.02M
28.77%-59.15M
-47.77%-85.51M
32.56%-57.50M
2783.22%220.10M
-127.30%-83.05M
-11.82%-57.87M
Net Profit
37.03%-92.53M
-119.83%-229.39M
8.45%-128.61M
286.45%123.55M
-2.90%-146.94M
-1026.51%-104.35M
4.70%-140.48M
22.31%-66.27M
-14.86%-142.80M
82.33%-9.26M
-213.69%-147.41M
18.88%-85.29M
-90.78%-124.32M
-123.34%-52.43M
43.02%-46.99M
-30.00%-105.14M
27.49%-65.17M
163.35%224.61M
-237.05%-82.47M
-215.47%-80.88M
Balance Sheet
Current assets
21.41%2.94B
14.13%2.99B
-7.18%2.52B
10.64%2.58B
0.13%2.42B
-0.82%2.62B
5.00%2.71B
-10.98%2.33B
-4.99%2.42B
19.94%2.64B
20.10%2.58B
19.42%2.62B
12.85%2.54B
-6.07%2.20B
-0.17%2.15B
-2.11%2.19B
13.26%2.25B
10.06%2.35B
-15.03%2.16B
-11.57%2.24B
Total current liabilities
186.30%716.59M
152.67%781.57M
196.64%903.46M
193.06%897.24M
-23.61%250.29M
-30.97%309.32M
-24.65%304.57M
6.32%306.16M
26.40%327.65M
43.82%448.09M
42.60%404.21M
7.53%287.98M
13.47%259.22M
29.52%311.56M
1.31%283.45M
-8.85%267.81M
-22.59%228.45M
-59.83%240.55M
14.40%279.78M
27.01%293.82M
Total assets
22.65%3.45B
17.32%3.52B
-1.56%3.03B
10.92%2.99B
1.77%2.81B
0.45%3.00B
5.01%3.08B
-9.42%2.69B
-4.20%2.76B
18.00%2.99B
21.14%2.93B
20.97%2.97B
14.53%2.89B
-2.98%2.53B
0.29%2.42B
-1.64%2.46B
12.03%2.52B
9.29%2.61B
-21.99%2.41B
-18.90%2.50B
Total liabilities
26.58%2.96B
25.65%3.03B
-0.14%2.42B
-3.05%2.35B
-5.28%2.34B
-7.22%2.42B
-7.63%2.42B
-4.54%2.43B
2.87%2.47B
32.76%2.60B
43.28%2.62B
38.85%2.54B
32.56%2.40B
6.58%1.96B
-3.01%1.83B
-4.33%1.83B
15.40%1.81B
11.75%1.84B
26.52%1.88B
28.99%1.91B
Total equity
3.30%491.41M
-16.87%489.09M
-6.72%617.97M
139.56%631.72M
60.44%475.73M
52.15%588.35M
110.00%662.47M
-38.43%263.70M
-39.06%296.51M
-32.50%386.69M
-46.92%315.46M
-31.44%428.30M
-31.43%486.57M
-25.77%572.89M
12.03%594.36M
7.22%624.73M
4.26%709.57M
3.83%771.74M
-66.97%530.54M
-63.46%582.67M
Cash Flow Statement
Net operating income
-425.83%-792.82M
-18.57%-137.71M
-14.30%-131.44M
226.24%151.34M
-0.56%-150.78M
-453.38%-116.14M
-5.47%-114.99M
-23.13%-119.88M
-11.90%-149.94M
116.42%32.87M
-346.28%-109.02M
-438.04%-97.36M
-323.36%-133.99M
-198.29%-200.19M
56.04%-24.43M
71.12%-18.10M
42.10%-31.65M
107.89%203.69M
-440.87%-55.57M
-41.69%-62.65M
Net investment
214.93%536.82M
-714.99%-419.50M
126.80%91.34M
-292.26%-120.07M
123.98%170.46M
355.36%68.21M
-595.98%-340.80M
-10.16%62.45M
123.37%76.11M
-112.59%-26.71M
137.36%68.71M
2203.96%69.52M
-13.25%-325.64M
123.06%212.15M
-250.80%-183.93M
96.73%-3.30M
-464.65%-287.55M
-49.37%95.11M
19.65%121.97M
-226.77%-101.03M
Net financing
2503.82%57.26M
1440.05%591.18M
-83.63%81.22M
-51.23%1.25M
-90.67%2.20M
-208.33%-44.12M
1637.32%496.05M
-98.22%2.56M
-95.21%23.57M
179.82%40.72M
-1859.38%-32.27M
11713.83%143.54M
6817.91%492.09M
18.36%-51.02M
25.79%1.83M
-99.61%1.22M
3.33%-7.33M
88.02%-62.49M
-86.67%1.46M
3629.01%314.54M

FAQs

What is the total revenue of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 943.71M, with a year-on-year change of 705.14M.

What are the current assets of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its current assets were 2.99B, with a year-on-year change of 14.13.

What are the total assets of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its total assets of Ionis Pharmaceuticals Inc were 3.52B, with a year-on-year change of 17.32.

What are the total liabilities of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Ionis Pharmaceuticals Inc were 3.03B, with a year-on-year change of 25.65.

What is the total equity of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its total equity of Ionis Pharmaceuticals Inc was 489.09M, with a year-on-year change of -16.87.

What is the net operating income of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Ionis Pharmaceuticals Inc was -381.68M, with a year-on-year change of 19.66.

What is the net investment of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its net investment of Ionis Pharmaceuticals Inc was -277.78M, with a year-on-year change of -107.25.

What is the net financing of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its net financing of Ionis Pharmaceuticals Inc was 675.84M, with a year-on-year change of 41.37.

What is the Earnings Per Share (EPS) of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -2.38, with a year-on-year change of 21.49.

What is the net income of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its net income was -381.39M, with a year-on-year change of 15.97.

What is the net margin of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -40.41, with a year-on-year change of 37.22.

What is the gross margin of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 98.31, with a year-on-year change of -0.10.

What is the debt-to-asset ratio of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 66.14, with a year-on-year change of 11.12.

What is the Return on Equity (ROE) of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -70.80, with a year-on-year change of 23.96.

What is the Return on Assets (ROA) of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -11.69, with a year-on-year change of 22.85.

What is the operating profit of Ionis Pharmaceuticals Inc?

According to Ionis Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -381.68M, with a year-on-year change of 19.66.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy